Alamar Biosciences Inc <ALMR.O>: Leerink Partners raises target price to $45 from $35
ALMR•Related News
Oil prices edge lower as Iran says it is open to diplomacy to end the war
XLE•
Mexico says fourth round of US trade talks postponed, October possible
EWW•
EssilorLuxottica, Meta unveil new generation of Ray-Ban Meta AI glasses at Meta Connect
META•
Bluerock Private Real Estate Fund director Ryan S. MacDonald acquires 10,400 common shares worth $124,522.32
BPRE•
Enterprise Financial Services Corp <EFSC.O>: StoneX initiates coverage with Buy rating; price target $70
EFSC•